Impact of COVID-19-related methadone regulatory flexibilities: views of state opioid treatment authorities and program staff.

Mitchell, S. G., Jester, J., Gryczynski, J., Whitter, M., Fuller, D., Halsted, C., & Schwartz, R. P. (2023). Impact of COVID-19-related methadone regulatory flexibilities: views of state opioid treatment authorities and program staff. Addict Sci Clin Pract, 18 (1), 61. https://doi.org/10.1186/s13722-023-00417-7.